SAN DIEGO, Oct. 3, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its subsidiary Kannaway® has garnered international news coverage in leading industry publication Direct Selling News.
An Oct. 1 Direct Selling News article entitled "Of Stalk And Stem — Kannaway's Growth Story" discusses Kannaway's rapid growth as the first direct selling company to sell cannabidiol (CBD) products around the world, highlighting the company's wide range of hemp products, including CBD oil supplements, CBD-infused skincare, hemp-based clothing and CBD pet products. The article features commentary and cites quotes from a Kannaway® executive explaining the popularity of CBD and the rapid growth trajectory of both the company and the industry as a whole.
"We are thrilled to have our growth story highlighted in this prestigious publication," said Kannaway® Chief Executive Officer Blake Schroeder. "Expanding our network of Brand Ambassadors and customer base, as well as increasing public knowledge about CBD will continue to be at the forefront of the company's vision."
Kannaway® is the first hemp lifestyle network to legally offer hemp-based botanical CBD wellness products. Last month, the company announced that the second quarter of 2018 was the largest-ever sales revenue quarter in its history as a result of its aggressive expansion plans throughout international markets such as Europe. The company's monthly revenue has grown more than 60 times since the re-launch of Kannaway® in March, 2016.
"It's incredible to see Kannaway recognized for its rapid revenue growth and dedication to cannabis education in the U.S. and throughout the world," said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. "With the U.S. hemp market poised to reach $1 billion by next year, we are poised to remain at the forefront of the CBD industry."
Direct Selling News is an online and print publication that direct selling executives turn to for information and resources to improve their companies. Designed to help busy decision-makers stay informed, this decade-old website features up-to-the-minute industry headlines and stock market updates.
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
SOURCE Medical Marijuana, Inc.